Health Matters | India Mustn't Take Shortcuts for Making Biosimilars, Confusing Affordability with Efficacy Bad Idea
Health Matters India shortcuts making biosimilars confusing affordability efficacy bad idea; generics biosimilars separate strategies approaches; Centre ensure tighter controls before approval periodic quality checks every batch consistent quality; biosimilar Adalimumab Zydus group; biosimilars generic equivalents biologic drugs a new class of medicines more complex than chemical generics; India poised another success story triumph capturing global market generic medicines; eyes trained on market for biosimilars; biologics products derived large molecules monoclonal antibodies gene therapies h...
Source: news18.com